Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 10, 2023

BUY
$69.91 - $75.81 $2,726 - $2,956
39 New
39 $2,000
Q2 2022

Aug 15, 2022

SELL
$59.26 - $71.14 $5,866 - $7,042
-99 Reduced 61.11%
63 $4,000
Q1 2022

May 17, 2022

SELL
$55.72 - $67.12 $1.86 Million - $2.24 Million
-33,392 Reduced 99.52%
162 $11,000
Q4 2021

Feb 15, 2022

BUY
$54.02 - $63.83 $54,884 - $64,851
1,016 Added 3.12%
33,554 $1.96 Million
Q3 2021

Nov 16, 2021

BUY
$55.56 - $60.79 $53,948 - $59,027
971 Added 3.08%
32,538 $1.95 Million
Q2 2021

Aug 11, 2021

BUY
$48.42 - $60.18 $45,417 - $56,448
938 Added 3.06%
31,567 $1.89 Million
Q1 2021

May 17, 2021

BUY
$47.16 - $54.44 $1,461 - $1,687
31 Added 0.1%
30,629 $1.52 Million
Q4 2020

Feb 16, 2021

BUY
$48.52 - $58.02 $44,929 - $53,726
926 Added 3.12%
30,598 $1.53 Million
Q3 2020

Nov 16, 2020

SELL
$53.07 - $61.1 $59,173 - $68,126
-1,115 Reduced 3.62%
29,672 $1.63 Million
Q2 2020

Aug 12, 2020

BUY
$43.1 - $55.31 $49,780 - $63,883
1,155 Added 3.9%
30,787 $1.63 Million
Q1 2020

May 14, 2020

SELL
$37.79 - $51.33 $387,574 - $526,440
-10,256 Reduced 25.71%
29,632 $1.32 Million
Q4 2019

Feb 14, 2020

SELL
$42.46 - $50.46 $164,532 - $195,532
-3,875 Reduced 8.85%
39,888 $1.99 Million
Q3 2019

Nov 14, 2019

BUY
$40.12 - $45.47 $74,743 - $84,710
1,863 Added 4.45%
43,763 $1.95 Million
Q2 2019

Aug 20, 2019

BUY
$37.28 - $41.68 $198,329 - $221,737
5,320 Added 14.54%
41,900 $1.73 Million
Q1 2019

May 10, 2019

SELL
$35.49 - $43.02 $74,316 - $90,083
-2,094 Reduced 5.41%
36,580 $1.48 Million
Q4 2018

Feb 14, 2019

BUY
$36.86 - $41.49 $1.43 Million - $1.6 Million
38,674 New
38,674 $1.47 Million

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $200B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Global Wealth Management Investment Advisory, Inc. Portfolio

Follow Global Wealth Management Investment Advisory, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Global Wealth Management Investment Advisory, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Global Wealth Management Investment Advisory, Inc. with notifications on news.